Showing results (41-50 of 355) with videos related to
Sort By:
Pageof 36
European Journal of Heart Failure|May 13, 2022
Changes in cardiac biomarkers in association with alterations in cardiac structure and function, and health status in heart failure with reduced ejection fraction: the EVALUATE-HF trialPeder L Myhre, Brian L Claggett, Amil M Shah, et al.Lancet (London, England)|May 25, 2020
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trialsMuthiah Vaduganathan, Brian L Claggett, Pardeep S Jhund, et al.Journal of the American Heart Association|November 19, 2021
Depressive Symptoms, Cardiac Structure and Function, and Risk of Incident Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction in Late LifeKatja Vu, Brian L Claggett, Jenine E John, et al.JAMA Cardiology|November 5, 2022
Population-Level Implications of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction in the USKhawaja M Talha, Javed Butler, Stephen J Greene, et al.Diabetes Research and Clinical Practice|November 21, 2022
Importance of NT-proBNP and conventional risk factors for prediction of death in older adults with and without diabetes mellitus- A report from the Atherosclerosis Risk in Communities (ARIC) studyMagnus O Wijkman, Brian L Claggett, Marcus V B Malachias, et al.Journal of Cardiac Failure|March 3, 2018
Pulmonary Congestion by Lung Ultrasound in Ambulatory Patients With Heart Failure With Reduced or Preserved Ejection Fraction and HypertensionKristin H Dwyer, Allison A Merz, Eldrin F Lewis, et al.Journal of the American Heart Association|May 17, 2021
Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection FractionSenthil Selvaraj, Brian L Claggett, Milton Packer, et al.Journal of the American College of Cardiology|February 22, 2023
Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With Heart FailureSafia Chatur, Brian L Claggett, Finnian R McCausland, et al.Circulation|April 1, 2026
Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities StudyMats C Højbjerg Lassen, John W Ostrominski, Brian L Claggett, et al.European Heart Journal. Acute Cardiovascular Care|April 28, 2025
The intersection of obesity and acute heart failure: Cardiac structure and function and congestion across BMI categoriesSofie Bøgh-Sørensen, Ross T Campbell, Brian L Claggett, et al.Pageof 36